国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000028 国药一致

午间休市 05-23 11:30:00

{"stockData":{"symbol":"000028","market":"SZ","secType":"STK","nameCN":"国药一致","latestPrice":37.75,"timestamp":1716435552000,"preClose":37.36,"halted":0,"volume":2761020,"delay":0,"floatShares":478000000,"shares":557000000,"eps":2.9212,"marketStatus":"午间休市","marketStatusCode":3,"change":0.39,"latestTime":"05-23 11:30:00","open":37.1,"high":38,"low":37.1,"amount":104000000,"amplitude":0.0241,"askPrice":37.77,"askSize":1,"bidPrice":37.75,"bidSize":9,"shortable":0,"etf":0,"ttmEps":2.9212,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716440400000},"adr":0,"adjPreClose":37.36,"symbolType":"stock","openAndCloseTimeList":[[1716427800000,1716435000000],[1716440400000,1716447600000]],"highLimit":41.1,"lowLimit":33.62,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":556565077,"pbRate":1.17,"roa":"--","roe":"2.21%","epsLYR":2.87,"committee":0.205882,"marketValue":21010000000,"floatMarketCap":18047000000,"peRate":12.922771,"changeRate":0.0104,"turnoverRate":0.0058,"status":0},"requestUrl":"/m/hq/s/000028","defaultTab":"news","newsList":[{"id":"2435014965","title":"华福证券：给予国药一致买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435014965","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435014965?lang=zh_cn&edition=full","pubTime":"2024-05-15 13:50","pubTimestamp":1715752229,"startTime":"0","endTime":"0","summary":"华福证券有限责任公司盛丽华,何展聪近期对国药一致进行研究并发布了研究报告《两广分销龙头，全国零售布局，经营潜力持续释放》，本报告对国药一致给出买入评级，当前股价为40.5元。公司作为全国领先的医药批发和零售平台， 批发业务深耕两广区域， 区域优势明显， 零售业务盈利能力释放潜能巨大， 首次覆盖， 给予“买入” 评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500021283.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431397121","title":"国药一致获信达证券买入评级，“提质增效”加速业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2431397121","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431397121?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:45","pubTimestamp":1714470305,"startTime":"0","endTime":"0","summary":"2024年4月30日，国药一致获信达证券买入评级，近一个月国药一致获得4份研报关注。考虑到公司当前估值存在弹性空间，并且国大药房的产品结构优化与提质增效有望加速，未来国大药房的利润率有望逐年提升。基于这些因素，信达证券首次覆盖国药一致，并给予“买入”投资评级。研报认为，国药一致具有“戴维斯双击”的潜质。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301745088b65c12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404301745088b65c12f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431397713","title":"信达证券：给予国药一致买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431397713","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431397713?lang=zh_cn&edition=full","pubTime":"2024-04-30 17:41","pubTimestamp":1714470100,"startTime":"0","endTime":"0","summary":"信达证券股份有限公司唐爱金,章钟涛近期对国药一致进行研究并发布了研究报告《“两广分销+全国零售”双网布局，”提质增效“加速业绩增长》，本报告对国药一致给出买入评级，当前股价为35.13元。　　国药一致(000028)　　核心投资逻辑： 我们认为国药一致具备“戴维斯双击”潜质。在估值方面，国药一致当前 PE-TTM 估值约为 12 倍（近 5 年 PE-TTM 平均估值约为13 倍，中特估 PE 估","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024043000040958.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431404971","title":"国药一致（000028）4月26日主力资金净买入45.90万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431404971","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431404971?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:23","pubTimestamp":1714353783,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月26日收盘，国药一致报收于35.11元，下跌2.42%，换手率1.33%，成交量6.37万手，成交额2.24亿元。近5日资金流向一览见下表：国药一致融资融券信息显示，融资方面，当日融资买入1359.7万元，融资偿还782.81万元，融资净买入576.89万元，连续3日净买入累计929.98万元。融券方面，融券卖出5000.0股，融券偿还4.06万股，融券余量32.32万股，融券余额1134.85万元。国药一致主营业务：医药分销和医药零售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900002480.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430231885","title":"国药(01099.HK)附属国药一致首季净利润3.89亿人民币  增长7.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430231885","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430231885?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:39","pubTimestamp":1714063140,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布，附属国药一致(000028.SZ) 第一季度报告，营业收入190.9亿人民币(下同)，按年增加2.2%。归属股东净利润3.89亿元，增长7.3%，每股收益70分。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-25 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/22末期业绩普通股息：人民币 0.872023/10/27第三季业绩无派息2023/08/28中期业绩无派息2023/04/28第一季业绩无派息 AASTOCKS新闻","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190401142440846_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345170/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430474282","title":"国药控股(01099)：国药一致(000028.SZ)首季归母净利约3.89亿元 同比增长7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430474282","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430474282?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:03","pubTimestamp":1714039427,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药控股(01099)公布国药一致(000028.SZ)2024年第一季度业绩，营业收入约190.9亿元，同比增长2.16%;净利润人民币 4.46 亿元，同比下降 3.19%;归属于上市公司股东的净利润约3.89亿元，同比增长7.33%;基本每股收益0.7元。公告称，净利下滑主要系零售板块上年同期理化诊断及口罩等应急物资品种销量较大，同时部分区域受门诊统筹等政策影响，导致本期业绩有所下滑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110075.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430478518","title":"国药一致最新公告：一季度净利润同比增长7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430478518","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430478518?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:33","pubTimestamp":1714033983,"startTime":"0","endTime":"0","summary":"国药一致披露2024年第一季度报告，实现营业收入190.9亿元，同比增长2.16%；归母净利润3.89亿元，同比增长7.33%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500033114.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430427534","title":"国药一致(000028.SZ)发布一季度业绩，净利润3.89亿元，增长7.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430427534","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430427534?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:08","pubTimestamp":1714032532,"startTime":"0","endTime":"0","summary":"智通财经APP讯，国药一致(000028.SZ)发布2024年一季度报告，报告期内实现营业收入190.9亿元，同比增长2.16%。归属于上市公司股东的净利润3.89亿元，同比增长7.33%。归属于上市公司股东的扣除非经常性损益的净利润3.7亿元，同比增长5.10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109699.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429850901","title":"【机构调研记录】渤海证券调研国药一致","url":"https://stock-news.laohu8.com/highlight/detail?id=2429850901","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429850901?lang=zh_cn&edition=full","pubTime":"2024-04-23 08:03","pubTimestamp":1713830593,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月22日披露的机构调研信息，渤海证券近期对1家上市公司进行了调研。调研上市公司名单如下：1）国药一致 （渤海证券参与公司业绩说明会&现场）个股亮点：B股:一致Ｂ(200028)于1993-08-09上市；公司携手腾讯公司,与3家医院签订了“互联网+智慧医院”合作框架协议；公司是国内较早研发冷链管理软硬件系统的企业，技术先进、成熟稳定，安全可靠以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300011577.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429185956","title":"【机构调研记录】国联基金调研国药一致、新余国科","url":"https://stock-news.laohu8.com/highlight/detail?id=2429185956","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429185956?lang=zh_cn&edition=full","pubTime":"2024-04-23 08:01","pubTimestamp":1713830517,"startTime":"0","endTime":"0","summary":"旗下最近一年表现最佳的基金产品为煤炭LOF，最新单位净值为2.02，近一年增长18.56%。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300011491.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428399593","title":"国药一致创60日新高，西南证券一日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2428399593","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428399593?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:25","pubTimestamp":1713342300,"startTime":"0","endTime":"0","summary":"今日国药一致创60日新高，收盘报34.0元。2024年4月16日，西南证券研究员杜向阳发布了对国药一致的研报《2023年门店稳健扩张，零售业务净利率提升》，该研报对国药一致给出“买入”评级。研报中预计2024-2026年归母净利润分别为17.7/19.4/21.9亿元，对应增速分别为10.7%/9.8%/12.5%，对应PE分别为10/9/8倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的朱言音。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-17/doc-inascsvw8548906.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-17/doc-inascsvw8548906.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425211614","title":"国药控股(01099.HK)附属国药一致去年赚15.99亿人民币  增长7.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425211614","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425211614?lang=zh_cn&edition=full","pubTime":"2024-04-07 20:20","pubTimestamp":1712492400,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布，附属国药一致(000028.SZ) 2023年度业绩，营业收入754.77亿人民币(下同)，按年增加2.8%。归属股东净利润15.99亿元，增长7.6%，每股收益2.87元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-05 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/03/22末期业绩普通股息：人民币 0.872023/10/27第三季业绩无派息2023/08/28中期业绩无派息2023/04/28第一季业绩无派息 AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180202161552248_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180202161552248_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340454/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2425906556","title":"国药一致(000028.SZ)发2023年度业绩，净利润15.99亿元，同比增长7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425906556","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2425906556?lang=zh_cn&edition=full","pubTime":"2024-04-07 17:46","pubTimestamp":1712483160,"startTime":"0","endTime":"0","summary":"国药一致发布2023年年度报告，报告期内公司实现营业收入754.77亿元，同比增长2.77%;归属于上市公司股东的净利润15.99亿元，同比增长7.57%;归属于上市公司股东的扣除非经常性损益的净利润15.33亿元，同比增长7.58%;基本每股收益2.87元/股。国药一致分销业务覆盖两广，公司药品和器械耗材分销、零售直销和零售诊疗等细分市场保持行业领先。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-07/doc-inaqzcvq6190774.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-07/doc-inaqzcvq6190774.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419496185","title":"国药控股：国药一致年度净利润15.99亿元 同比增长7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419496185","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2419496185?lang=zh_cn&edition=full","pubTime":"2024-03-15 09:06","pubTimestamp":1710464760,"startTime":"0","endTime":"0","summary":"　　国药控股发布国药一致年度业绩快报，公司实现营业收入人民币754.77亿元，同比增长2.77%；营业利润24.67亿元，同比增长7.00%；利润总额24.73亿元，同比增长7.02%；归属于上市公司股东的净利润15.99亿元，同比增长7.57%；扣除非经常性损益后的归属于上市公司股东的净利润15.33亿，同比增长7.58%；基本每股收益2.87元。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-15/doc-inankawv8846897.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-15/doc-inankawv8846897.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2419987615","title":"国药(01099.HK)附属国药一致全年赚15.99亿人民币  增长7.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419987615","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2419987615?lang=zh_cn&edition=full","pubTime":"2024-03-15 00:46","pubTimestamp":1710434760,"startTime":"0","endTime":"0","summary":"国药控股(01099.HK) 公布，附属国药一致(000028.SZ) 2023年度业绩快报，实现营业收入754.77亿人民币(下同)，按年增加2.8%。归属股东净利润15.99亿元，增长7.6%，每股收益2.87元。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-03-14 16:25。) (A股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2023/10/27第三季业绩无派息2023/08/28中期业绩无派息2023/04/28第一季业绩无派息 2023/03/27末期业绩普通股息：人民币 0.8200﹙相当于港元 0.9000﹚AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190401142440189_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190401142440189_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1333536/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2419567075","title":"国药一致(000028.SZ)：2023年度净利润15.99亿元 同比增长7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419567075","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2419567075?lang=zh_cn&edition=full","pubTime":"2024-03-14 19:57","pubTimestamp":1710417420,"startTime":"0","endTime":"0","summary":"国药一致(000028.SZ)发布2023年度业绩快报，营业总收入754.77亿元，同比增长2.77%;归属于上市公司股东的净利润15.99亿元，同比增长7.57%;扣除非经常性损益后的归属于上市公司股东的净利润15.33亿元，同比增长7.58%;基本每股收益2.87元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-14/doc-inanhzmi9349997.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-14/doc-inanhzmi9349997.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2416293146","title":"“不差钱”的连锁药店们，疯狂烧钱扩张","url":"https://stock-news.laohu8.com/highlight/detail?id=2416293146","media":"新周刊","top":-1,"share":"https://www.laohu8.com/m/news/2416293146?lang=zh_cn&edition=full","pubTime":"2024-03-02 15:29","pubTimestamp":1709364540,"startTime":"0","endTime":"0","summary":"　　连锁药店巨头在扩张的道路上一路狂飙，背后是难以缓解的“资金饥渴症”。　　截至目前，连锁药店的头部企业已经悉数进入“万店时代”，但我国药店行业仍然处于“跑马圈地”阶段。　　规模化是连锁经营的核心内容，开店是连锁药店们永恒的主题。　　为了抢夺优质标的，连锁药店们向来舍得一掷千金。　　从财务报表来看，头部的连锁药店们并“不差钱”。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/wm/2024-03-02/doc-inakxiik6490914.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2024-03-02/doc-inakxiik6490914.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2402216329","title":"国药一致增资至5.5亿元 增幅30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2402216329","media":"港股那点事","top":-1,"share":"https://www.laohu8.com/m/news/2402216329?lang=zh_cn&edition=full","pubTime":"2024-01-12 18:22","pubTimestamp":1705054920,"startTime":"0","endTime":"0","summary":"据天眼查，1月10日，国药一致发生工商变更，注册资本由约4.28亿人民币增至约5.57亿人民币，增幅30%。               \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-01-12/doc-inachiyu1898649.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-01-12/doc-inachiyu1898649.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1993-08-09","address":"广东省深圳市福田区园岭街道八卦四路15号一致药业大厦","stockEarnings":[{"period":"1week","weight":-0.0676},{"period":"1month","weight":0.0456},{"period":"3month","weight":0.1474},{"period":"6month","weight":0.2056},{"period":"1year","weight":-0.1329},{"period":"ytd","weight":0.2887}],"companyName":"国药集团一致药业股份有限公司","boardCode":"AI0051","perCapita":"--","boardName":"批发业","registeredCapital":"55656万元","compareEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0569},{"period":"6month","weight":0.0387},{"period":"1year","weight":-0.027},{"period":"ytd","weight":0.0617}],"survey":"　　国药集团一致药业股份有限公司是集制药工业、医药批发、零售连锁为一体的医药上市公司,控股股东为国药控股有限公司。主要经营医药企业受托管理、资产重组,医药实业投资项目的咨询服务,举办医疗器械的展览展销,中药材、中成药、中药饮片、化学原料药、化学药制剂、抗生素、生化药品、生物制品的批发(经营期限以许可证为准)。公司坚持走研发、制药、分销、物流、零售一体化发展道路,旗下拥有致君制药、万乐公司、一致药店等公司,其中一致药店为国内最大规模的连锁药店之一，公司属下国大药房是全国销售规模领先的医药零售企业，是国内少数拥有全国性直营药品零售网络的企业之一。","serverTime":1716435555739,"listedPrice":3.5,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国药一致,000028,国药一致股票,国药一致股票老虎,国药一致股票老虎国际,国药一致行情,国药一致股票行情,国药一致股价,国药一致股市,国药一致股票价格,国药一致股票交易,国药一致股票购买,国药一致股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国药一致(000028)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国药一致(000028)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}